Back
Ionis Pharmaceuticals 10K Form
Buy
76
IONS
Ionis Pharmaceuticals
Last Price:
51.50
Seasonality Move:
3.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2023-05-03 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-11-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
| 2022-05-04 | 10Q | IONS/Ionis Pharmaceuticals Quarterly |
Receive IONS News And Ratings
See the #1 stock for the next 7 days that we like better than IONS
IONS Financial Statistics
Sales & Book Value
| Annual Sales: | $587.37M |
|---|---|
| Cash Flow: | $-112.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.20 |
| Price / Book: | 23.43 |
Profitability
| EPS (TTM): | -2.87000 |
|---|---|
| Net Income (TTM): | $-409.45M |
| Gross Margin: | $573.25M |
| Return on Equity: | -85.39% |
| Return on Assets: | -14.89% |
Ionis Pharmaceuticals Earnings Forecast
Key Ionis Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 33 years for IONS is 97.60%.
- The Selling, General & Administrative Expenses for IONS have been equal to 25.59% of Gross Profit Margin.
- The Research & Development expenses have been 141.84% of Revenue.
- The Interest Expense is -1.04% of Operating Income.
- The Net Earning history of IONS is -45.92% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 16 years.
Ionis Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | IONS |
| CUSIP: | 462222 |
| Website: | ionispharma.com |
Debt
| Debt-to-Equity Ratio: | 4.06 |
|---|---|
| Current Ratio: | 6.39 |
| Quick Ratio: | 5.88 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IONS Technical Analysis vs Fundamental Analysis
Buy
76
Ionis Pharmaceuticals (IONS)
is a Buy
Is Ionis Pharmaceuticals a Buy or a Sell?
-
Ionis Pharmaceuticals stock is rated a Buy
The current Ionis Pharmaceuticals [IONS] share price is $51.52. The Score for IONS is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.